1Lionetto R, Pugliese V, Bruzzi P, et al. No standard treatment is available for advanced pancreatic cancer[ J]. Eur Cancer, 1995,31 (6) :882-887.
2Cosimo S, Claudio P, Sergio P. Ductal adenocarcinoma of the body and tail of the pancreas [J]. J Am Coll Surg, 1997, 185(3) : 255-259.
3Barkin JS, Goldstein JA. Diaglnostic and therapeutic approach to pancreatic cancer. [J]. Bio Med Pharmacother, 2000, 54(7) :400-409.
4Symon Z, Davis M, McGinn CJ, et al. Concurrent chemotherapy with gemcitable and cisplantin for pancreatic cancer:from laboratory to the clinic[J]. Int J Radiat Oncol Biol Phys, 2002, 53:140-145.
5Mohiuddin M, Begine WF, Stevens J, et al. Combined intraoperative radiation and perioperative chemotherapy for unresectable cancer of the pancreas[J]. J Clin Oncol, 1995, 13(11):2764-2768.
6Handley SW. Pancreatic cancer and the treatment by implanted radium [J]. Ann Surg, 1934, 100: 215-222.
7Peretz T, Nori D, Hilaris B, et al. Treatment of primary unresectable carcinoma of the pancreas with I-125 implantation[ J].Int J Radiat Oncol Biol Phys, 1989,17 (5) :931-935.
8Anderson LL, Kuan HM, Ding IY. Clinical dosimetry with ^125I[A]. In Gorge . Modem interstitial and intracavitary radiation cancer management [ C ]. New York: Masson Publishing, 1981.316-317.
9Williamson JF. Physics of radiation oncology[ C ]. Third Edition. Philadelphia: Lippincott-Raven, 1997.213 -215.
4Williamson JF, Coursey BM, Dewerd LA, et al. Guidence to users of Nycomed Amersham and North American Scientific, lnc, 1-125 interstitial sources: dosimetry and calibration changes: recommendations of the American Association of Physicists in Medicine Radiation Therapy Committee Ad Hoc Subcommittee on Low-energy Seed Dosimetry. Med Phys. 1999,26 : 570-573.
5Chen Y, Stanton RE, Hoist R J, et al. Treatment planning for prostate implant with loose seeds. Med Phys, 1997,24 : 1141-1145.
7Grimm PD, Blasko JC, Sylvester JE, et al. lO-year biochemical (prostate specific antigen) control of prostate cancer with ^125l brachylherapy, Int J Radiat Oncol Biol Phys,2001,51 :31-40.
8Ragde H, Korb LJ, Elgamal AA, et al. Modem prostate brachytherapy: postate specific antigen results in 219 patients with up to 12 years of observed follow-up. Cancer, 2000,89 : 135-141.
9Ragde H, Grado GL, Nadir BS. Brachytherapy for clinically localized prostate cancer: thirteen-year disease-free survival of 769 consecutive prostate cancer patients treated with permanent implants alone. Arch Esp Urol, 2001,54 : 739-747.
10Chen A, Galloway M, Landreneau R, et al. lntraoperative 1-125 brachytherapy for high-risk stage 1 non-small cell lung carcinoma. Int J Radiat Oncol Biol Phys, 1999,44: 1057-1063.
